Skip to Content

Nymalize Approval History

  • FDA approved: Yes (First approved May 10th, 2013)
  • Brand name: Nymalize
  • Generic name: nimodipine
  • Company: Arbor Pharmaceuticals
  • Treatment for: Subarachnoid Hemorrhage

Nymalize (nimodipine) is a calcium channel blocker indicated to improve neurological outcome following subarachnoid hemorrhage.

Development History and FDA Approval Process for Nymalize

May 13, 2013Approval Arbor Pharmaceuticals Announces FDA Approval of Nymalize

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.